clofarabine has been researched along with Bladder Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, W; Brettner, R; Bruchbacher, A; Clozel, T; Compérat, E; Elemento, O; Ertl, IE; Gutmann, M; Haitel, A; Hassler, MR; Ilijazi, D; Koren, A; Kronabitter, H; Kubicek, S; Lardeau, CH; Lemberger, U; Mohr, T; Oszwald, A; Shariat, SF; Vician, P; Wasinger, G; Zeitler, G | 1 |
1 other study(ies) available for clofarabine and Bladder Cancer
| Article | Year |
|---|---|
Molecular and Pharmacological Bladder Cancer Therapy Screening: Discovery of Clofarabine as a Highly Active Compound.
Topics: Animals; Carcinoma, Transitional Cell; Clofarabine; Early Detection of Cancer; Humans; Mice; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Urinary Bladder Neoplasms | 2022 |